Frederic Oudea

Frederic Oudea is a declared insider at 2 companies (board member); the most frequent names are Societe Generale and Sanofi. Between 31 March 2021 and 2 May 2023, the trades on record add up to 5 filings.

No open-market sale appears; the market trades are 2 purchases worth €88k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 3 share grants. So far in 2023, the count stands at 1 purchase and no sales.

The newest entry dates from 4 May 2023: an open-market purchase of €49k, in Sanofi. The median gap between a trade and its publication by AMF is 3 days. For comparison, MAR article 19 gives managers three business days to notify a trade. Source: insider filings from AMF. Past trades are no guide to future returns.